Last analyzed: May 28, 2026 (Q1 FY26)

Moderna, Inc.

MRNA

Biotechnology

$47.57

Market Cap

$19M

P/E Ratio

-11.186379

Revenue Rank

Rank 4

Margin Rank

Rank 3

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks